BioSpace News Archive

Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health; the Translational Genomics Research Institute, part of City of Hope, a nonprofit biomedical research center; and OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced a new research study.

RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the appointment of Michael Mendicino, Ph.D. to its Scientific Advisory Board.

ATCC to provide biological standards to support research efforts of the Targeted Evaluation of Ionizing Radiation Exposure (TEI-REX) program. MANASSAS, Va.--( BUSINESS WIRE )-- ATCC , the world’s premier biological materials management and standards organization, today announced that it would be supporting Areté , one of the four winning teams awarded a contract from the Intelligence Advanced Research Projects Activity ( IARPA ), the research and development arm of the Office of the D

ReCode Therapeutics announced today that it will receive a strategic investment from the Cystic Fibrosis Foundation (CF Foundation) to develop ReCode’s inhaled mRNA-based therapeutic for people with cystic fibrosis (CF), including those with genotypes that do not respond to approved CFTR modulators.

A newly published clinical study shows that NeurOptics’ Automated Pupillometry and the Neurological Pupil index™ (NPi®) remain unaffected by clinical intoxication, and therefore can be used for rapidly screening emergency room patients for brain injury or neurological injuries regardless of intoxicated state.

Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics.

Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) appointed prominent physician and key opinion leader Brian E. Lacy, M.D., Ph.D., a board-certified gastroenterologist at Mayo Clinic, to its Scientific Advisory Board.

Motus GI Holdings, Inc. announced today it has initiated a process to explore a range of strategic and financing alternatives focused on maximizing stockholder value and accelerating commercialization of the Pure-Vu System.

Agenus today announced that Dr. Garo Armen, Chairman and CEO of Agenus, and Dr. Steven O’Day, Chief Medical Officer, will participate in a virtual fireside chat at the B Riley Securities’ 2023 Virtual Oncology Conference on Wednesday, January 18th at 11:30am ET.

Milestone Scientific Inc. today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Brazil.